## EMN: Eastman Chemical Company - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.3% in lower entry zone (4.0-10.0%), top quartile (82nd pct) cross-sectional ranking. Short-term MRS_5 (4.8%) confirms momentum alignment. Strong momentum (+6.5% 5-day acceleration). Outperforming sector by 5.3%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($61.80)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Shareholders to Receive Increased Dividend as Eastman (EMN) Extends 16-Year Streak**
- Source: Insider Monkey | 20251209T204200 | Bullish | Relevance: 99%
-  Eastman Chemical Company (NYSE: EMN) has announced a 1.2% increase in its quarterly dividend to $0.84 per share, extending its dividend growth streak to 16 years. This move, payable January 8, 2026, reflects the company's commitment to shareholder value, consistent earnings, and strong cash generation. Eastman is also targeting $100 million in cost cuts for 2026, building on $75 million already achieved, while generating $402 million in operating cash flow in Q3 2025.

**2. We Wouldn't Be Too Quick To Buy Eastman Chemical Company (NYSE:EMN) Before It Goes Ex-Dividend**
- Source: Simply Wall Street | 20251210T110815 | Neutral | Relevance: 99%
-  Eastman Chemical Company (NYSE:EMN) is approaching its ex-dividend date of December 15th, with a dividend payment of US$0.84 per share. While the company's earnings have seen modest growth, its dividend payout ratio is 55% of profit, and it paid out 96% of its free cash flow in dividends last year, raising concerns about sustainability and cash flow coverage. Investors should consider these factors and potential risks despite the steady dividend growth over the past decade.

**3. We Wouldn't Be Too Quick To Buy Eastman Chemical Company (NYSE:EMN) Before It Goes Ex-Dividend**
- Source: Simply Wall Street | 20251210T110826 | Neutral | Relevance: 99%
- Eastman Chemical Company (NYSE:EMN) is about to pay a dividend, but the article advises caution before buying for this reason. The company's dividend payout is 55% of profits but 96% of free cash flow, raising concerns about sustainability. While earnings per share have grown modestly, the dividend's coverage by cash flow is a red flag for potential investors.

**4. Shareholders to Receive Increased Dividend as Eastman (EMN) Extends 16-Year Streak**
- Source: Finviz | 20251210T050832 | Bullish | Relevance: 98%
- Eastman Chemical Company (EMN) announced a 1.2% increase in its quarterly dividend to $0.84 per share, extending its dividend growth streak to 16 years. This move, payable January 8, 2026, reaffirms the company's commitment to shareholder value and is supported by strong cash generation and ongoing cost reduction initiatives. Eastman Chemical aims for $100 million in cost cuts for 2026, building on $75 million achieved this year, while reporting $402 million in operating cash flow in Q3 2025.

**5. Shareholders to Receive Increased Dividend as Eastman (EMN) Extends 16-Year Streak**
- Source: Insider Monkey | 20251209T204200 | Bullish | Relevance: 98%
-  Eastman Chemical Company (NYSE: EMN) has announced a 1.2% increase in its quarterly dividend to $0.84 per share, marking its 16th consecutive year of dividend growth. The company, which is prioritizing cash generation and cost reduction, aims to deliver continued value to shareholders. EMN generated $402 million in operating cash flow in Q3 2025 and distributed $146 million to shareholders through dividends and share repurchases.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.08M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.2%)
- Blackrock Inc.: 7.0% (+0.9%)
- State Street Corpora: 5.0% (+24.3%)
- Capital Research Glo: 3.7% (-1.0%)
- Dimensional Fund Adv: 3.5% (+14.4%)

### Key Risks

1. Valuation risk: PEG 3.6x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 9.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +6.5% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.59 signals overvaluation risk, limited margin of safety. Forward P/E 10.5x attractive for 15% earnings growth. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.6B |
| Beta | 1.25 |
| 52W Range | $56.11 - $103.82 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.59 |
| Forward P/E | 10.5 |
| Current P/E | 12.0 |
| YoY Growth | 14.6% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -0.2% to 6.3% (+6.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 82nd percentile. MRS_5 at 4.8% confirms short-term momentum alignment. AM_20 at 8.6% shows strong absolute momentum above own 20MA. Outperforming sector by 5.3pp, stock-specific strength. Below SMA200 (0.90x), long-term trend not supportive. MACD histogram positive (0.61), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.27% (CS: 82) | Strong |
| RSI_14 | 64.3 | Neutral |
| MACD Histogram | 0.61 | Bullish |
| vs SMA20 | 1.085x | Above |
| vs SMA50 | 1.078x | Above |
| vs SMA200 | 0.903x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $65.84
- **Stop Loss:** $61.80 (6.1% risk)
- **Target:** $71.90 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 341
- **Position Value:** $22,451.44
- **Portfolio %:** 22.45%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-29 (Est: $0.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.14 | -2.2% |
| 2025Q2 | $1.75 | $1.60 | -8.7% |
| 2025Q1 | $1.89 | $1.91 | +1.2% |
| 2024Q4 | $1.57 | $1.87 | +18.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*